Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 Goldman Sachs GS Feb 6, 2026 928.75 +4.31   
 Home Depot HD Feb 6, 2026 385.15 +0.73   
 Honeywell International HON Feb 6, 2026 238.38 +1.94   
 IBM IBM Feb 6, 2026 298.93 +3.12   
 Johnson & Johnson JNJ Feb 6, 2026 239.99 +0.93   
 JP Morgan Chase JPM Feb 6, 2026 322.40 +3.95   
 McDonalds MCD Feb 6, 2026 327.16 +1.14   
 Merck & Co MRK Feb 6, 2026 121.93 +1.82   
 Microsoft MSFT Feb 6, 2026 401.14 +1.90   
 Nasdaq Combined Composite Index COMPX Feb 6, 2026 23 031.21 +2.18   
 Nike NKE Feb 6, 2026 63.92 +1.95   
 NVIDIA NVDA Feb 6, 2026 185.41 +7.87   
 Procter & Gamble PG Feb 6, 2026 159.17 +0.35   
 Salesforce CRM Feb 6, 2026 191.35 +0.73   
 Sherwin-Williams SHW Feb 6, 2026 361.98 +0.26   
 Travelers Companies TRV Feb 6, 2026 301.49 +0.39   
 UnitedHealth Group UNH Feb 6, 2026 276.65 +3.02   
 Verizon Communications VZ Feb 6, 2026 46.31 -1.68   
 Visa V Feb 6, 2026 331.58 +0.74   
 Walmart WMT Feb 6, 2026 131.18 +3.34   
 Walt Disney DIS Feb 6, 2026 108.70 +3.55   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.